Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Maiko Wada-Ohno"'
A Case of Skin Metastasis of Digital Papillary Adenocarcinoma with Clinical Appearance of Hard Edema
Publikováno v:
Nishi Nihon Hifuka. 84:56-59
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1119181f52e765a386cd3f6779b4f1a
https://doi.org/10.2336/nishinihonhifu.84.56
https://doi.org/10.2336/nishinihonhifu.84.56
Autor:
Hiroki Hashimoto, Yuichi Yamada, Fumitaka Ohno, Maiko Wada-Ohno, Yoshinao Oda, Hiromi Morisawa, Takamichi Ito, Masutaka Furue, Toshio Ichiki, Yasuko Shiomichi
Publikováno v:
Nishi Nihon Hifuka. 83:227-232
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93028888552a41e4a69ab444210c862f
https://doi.org/10.2336/nishinihonhifu.83.227
https://doi.org/10.2336/nishinihonhifu.83.227
Autor:
Hiroki HASHIMOTO, Gaku TSUJI, Konosuke NAGAE, Sumire NAKAMOTO, Ayaka ETO, Fumitaka OHNO, Maiko WADA-OHNO, Takamichi ITO, Takeshi NAKAHARA, Masutaka FURUE
Publikováno v:
Nishi Nihon Hifuka. 83:38-41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5b3dcc6ac7116b2d81bd8e5ab99808f
https://doi.org/10.2336/nishinihonhifu.83.38
https://doi.org/10.2336/nishinihonhifu.83.38
Autor:
Maiko Wada-Ohno, Sumire Nakamoto, Yuki Sato, Masutaka Furue, Takamichi Ito, Fumitaka Ohno, Ayaka Eto, Hiroki Hashimoto, Konosuke Nagae
Publikováno v:
Nishi Nihon Hifuka. 82:433-437
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62d9e23820d02921545c7cc346d281d0
https://doi.org/10.2336/nishinihonhifu.82.433
https://doi.org/10.2336/nishinihonhifu.82.433
Autor:
Taketoshi Ide, Masutaka Furue, Maiko Yoshida, Noriko Kitagawa, Takeshi Nakahara, Shoko Yogo, Maiko Wada-Ohno, Makiko Kido-Nakahara, Gaku Tsuji, Seisho Sato
Publikováno v:
Nishi Nihon Hifuka. 82:23-27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2991b1a704738ddbda548d5900e62bf6
https://doi.org/10.2336/nishinihonhifu.82.23
https://doi.org/10.2336/nishinihonhifu.82.23
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 811, p 811 (2021)
Volume 10
Issue 4
Journal of Clinical Medicine, Vol 10, Iss 811, p 811 (2021)
Volume 10
Issue 4
The efficacy of preoperative imaging for acral melanoma (AM) has not been fully evaluated. We examined the accuracy of imaging modalities in the detection of nodal and distant metastases in patients with AM. A retrospective review of 109 patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d40a9fad737ec125e419364ce223cf5f
http://europepmc.org/articles/PMC7921989
http://europepmc.org/articles/PMC7921989
Publikováno v:
Journal of Clinical Medicine
Volume 9
Issue 7
Journal of Clinical Medicine, Vol 9, Iss 2266, p 2266 (2020)
Volume 9
Issue 7
Journal of Clinical Medicine, Vol 9, Iss 2266, p 2266 (2020)
In this retrospective review of 100 patients with primary invasive acral melanoma, we examined whether narrow-margin excision is warranted for acral melanoma. Patients treated with surgical margins recommended by the National Comprehensive Cancer Net
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a94f84df2fab6b016284861339e7971a
Autor:
Yuka Tanaka, Fumitaka Ohno, Yuichi Yamada, Yumiko Kaku-Ito, Maho Murata, Yoshinao Oda, Masutaka Furue, Maiko Wada-Ohno, Takamichi Ito, Toshio Ichiki, Taketoshi Ide, Yuki Kuma
Publikováno v:
International Journal of Molecular Sciences
Volume 20
Issue 24
Volume 20
Issue 24
The current development of BRAF inhibitors has revolutionized the treatment of unresectable melanoma. As the potential heterogeneity of BRAF mutations in melanoma has been reported, accurate detection of BRAF mutations are important. However, the gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c0ae4c4467b408c301ce291df418055
Publikováno v:
Current Treatment Options in Oncology. 20
In recent years, the number of patients with malignant melanoma has continued to increase globally; surgery remains the first treatment option for patients with resectable melanoma. Adjuvant therapy for patients with stage III and IV melanoma followi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53899e278de88d7e43308db583f97cbf
https://doi.org/10.1007/s11864-019-0666-x
https://doi.org/10.1007/s11864-019-0666-x